2'-cyano-2'-deoxyarabinofuranosylcytosine and Cancer of Ovary

2'-cyano-2'-deoxyarabinofuranosylcytosine has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Cheng, N; Jiang, Y; Liu, X; Nowak, B; Plunkett, W; Qiang, B	1

Other Studies

1 other study(ies) available for 2'-cyano-2'-deoxyarabinofuranosylcytosine and Cancer of Ovary

Article	Year
Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations. Cancer chemotherapy and pharmacology, 2018, Volume: 81, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Cell Line, Tumor; Chromosome Aberrations; Cytarabine; DNA Damage; Drug Synergism; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Poly (ADP-Ribose) Polymerase-1; Tumor Stem Cell Assay	2018

Article

Year

Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations.

Cancer chemotherapy and pharmacology, 2018, Volume: 81, Issue:2

Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Cell Line, Tumor; Chromosome Aberrations; Cytarabine; DNA Damage; Drug Synergism; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Poly (ADP-Ribose) Polymerase-1; Tumor Stem Cell Assay

2018